Showing results (111-120 of 120) with videos related to
Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Journal of Travel Medicine|March 4, 2020
Meningococcal and pneumococcal carriage in Hajj pilgrims: findings of a randomized controlled trialAl-Mamoon Badahdah, Marwan A Bakarman, Ameneh Khatami, et al.The Journal of Infectious Diseases|December 11, 2021
A Gonococcal Vaccine Has the Potential to Rapidly Reduce the Incidence of Neisseria gonorrhoeae Infection Among Urban Men Who Have Sex With MenBen B Hui, Thilini N Padeniya, Nic Rebuli, et al.Plos Computational Biology|November 4, 2021
Modelling response strategies for controlling gonorrhoea outbreaks in men who have sex with men in AustraliaQibin Duan, Chris Carmody, Basil Donovan, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 30, 2016
The Molecular Epidemiology and Antimicrobial Resistance of Neisseria gonorrhoeae in Australia: A Nationwide Cross-Sectional Study, 2012Ella Trembizki, Handan Wand, Basil Donovan, et al.BMJ Open|May 8, 2024
Comprehensive observational study evaluating the enduring effectiveness of 4CMenB, the meningococcal B vaccine against gonococcal infections in the Northern Territory and South Australia, Australia: study protocolHelen Marshall, James Ward, Bing Wang, et al.Emerging Infectious Diseases|August 19, 2017
Molecular Antimicrobial Resistance Surveillance for Neisseria gonorrhoeae, Northern Territory, AustraliaDavid M Whiley, Ella Trembizki, Cameron Buckley, et al.Plos Medicine|July 27, 2017
Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicinesEmilie Alirol, Teodora E Wi, Manju Bala, et al.BMJ Open|April 16, 2024
Multicentre double-blind randomised placebo-controlled trial evaluating the efficacy of the meningococcal B vaccine, 4CMenB (Bexsero), against Neisseria gonorrhoeae infection in men who have sex with men: the GoGoVax study protocolKate L Seib, Basil Donovan, Caroline Thng, et al.The Lancet Regional Health. Western Pacific|September 9, 2025
Antimicrobial resistance in Neisseria gonorrhoeae in nine sentinel countries within the World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), 2023: a retrospective observational studyIsmael Maatouk, Phiona Vumbugwa, Thitima Cherdtrakulkiat, et al.The New England Journal of Medicine|July 8, 2026
Meningococcal B Vaccine to Prevent Neisseria gonorrhoeae InfectionKate L Seib, Basil Donovan, Fengyi Jin, et al.Pageof 12